Kate Gunther
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target.
Journal: Frontiers in pharmacology
Published: October 01, 2025
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Patient-derived epithelial cell organoids mimic the phenotypic complexity of endometriosis subtypes.
Patient-derived epithelial cell organoids mimic the phenotypic complexity of endometriosis subtypes.
Journal: Human reproduction (Oxford, England)
Published: June 23, 2025
Medical management of endometriosis.
Journal: Current opinion in obstetrics & gynecology
Published: August 19, 2024
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer.
Journal: Cancer research
Published: November 28, 2022
ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
Journal: Scientific reports
Published: April 28, 2020
Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight.
Journal: PloS one
Published: July 18, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026